Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Eliquis’ European Label Supports Superiority Claims

Nov 21 2012

• By Emily Hayes

Related Content

Mini Sentinel Alleviates FDA Concern Over Pradaxa Bleeding Issue

Nov 02 2012

Bristol Signals Dapaglifozin’s Back On Track, Plans FDA Resubmission

Oct 24 2012

Apixaban Shows Mortality Advantage, But Will It Survive FDA Scrutiny?

Sep 05 2011

Doubts Linger Over Whether AVERROES Gives Any Advantage To Apixaban

Feb 14 2011

Pradaxa Bleeding Deaths Spur FDA Concerns, European Label Changes

Dec 07 2011

Oral Anticoagulants Market Snapshot: Big Bucks, But Payers Are On Guard

Oct 25 2010

Related Companies

Bristol Myers Squibb Company

Pfizer Inc.

Boehringer Ingelheim GmbH

Johnson & Johnson

Bayer AG

Additional Topics

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window